Literature DB >> 28435136

Chitosan enhances nanoparticle delivery from the reproductive tract to target draining lymphoid organs.

Jaehyung Park1, Renuka Ramanathan1, Linhchi Pham1, Kim A Woodrow2.   

Abstract

To prime adaptive immune responses from the female reproductive tract (FRT), particulate antigens must be transported to draining lymph nodes (dLNs) since there are no local organized lymphoid structures equivalent to those found in the respiratory or gastrointestinal tracts. However, little is known about how to safely and effectively navigate successive barriers to transport such as crossing the epithelium and gaining access to migratory cells and lymphatic drainage that provide entry into dLNs. Here, we demonstrate that intravaginal pre-treatment with chitosan significantly facilitates translocation of nanoparticles (NPs) across the multilayered vaginal epithelium to target dLNs. In addition, chitosan pre-treatment was found to enhance NP associations with immunogenic antigen presenting cells in the vaginal submucosa. These observations indicate that chitosan may have great potential as an adjuvant for both local and systemic protective immunity against viral infections in the FRT.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chitosan; Draining lymph node; Mucosal delivery; Nanoparticle; Reproductive tract

Mesh:

Substances:

Year:  2017        PMID: 28435136      PMCID: PMC5544568          DOI: 10.1016/j.nano.2017.04.012

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  59 in total

1.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Authors:  Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

Review 2.  Nanoparticle-based vaginal drug delivery systems for HIV prevention.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Expert Opin Drug Deliv       Date:  2010-01       Impact factor: 6.648

3.  Vaginal langerhans cells nonproductively transporting HIV-1 mediate infection of T cells.

Authors:  Lamar Ballweber; Barry Robinson; Allison Kreger; Michael Fialkow; Gretchen Lentz; M Juliana McElrath; Florian Hladik
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 4.  Antiviral immune responses in the genital tract: clues for vaccines.

Authors:  Akiko Iwasaki
Journal:  Nat Rev Immunol       Date:  2010-09-10       Impact factor: 53.106

5.  Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance.

Authors:  Elizabeth M Steinert; Jason M Schenkel; Kathryn A Fraser; Lalit K Beura; Luke S Manlove; Botond Z Igyártó; Peter J Southern; David Masopust
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

6.  Novel vaccination protocol with two live mucosal vectors elicits strong cell-mediated immunity in the vagina and protects against vaginal virus challenge.

Authors:  Zhongxia Li; Manxin Zhang; Chenghui Zhou; Xinyan Zhao; Norifumi Iijima; Fred R Frankel
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

7.  Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.

Authors:  Donato Cosco; Felisa Cilurzo; Jessica Maiuolo; Cinzia Federico; Maria Teresa Di Martino; Maria Chiara Cristiano; Pierfrancesco Tassone; Massimo Fresta; Donatella Paolino
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

8.  Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection.

Authors:  Qing Zhu; James Talton; Guofeng Zhang; Tshaka Cunningham; Zijian Wang; Robert C Waters; James Kirk; Bärbel Eppler; Dennis M Klinman; Yongjun Sui; Susan Gagnon; Igor M Belyakov; Russell J Mumper; Jay A Berzofsky
Journal:  Nat Med       Date:  2012-07-15       Impact factor: 53.440

9.  Nanoparticle transport from mouse vagina to adjacent lymph nodes.

Authors:  Byron Ballou; Susan K Andreko; Elvira Osuna-Highley; Michael McRaven; Tina Catalone; Marcel P Bruchez; Thomas J Hope; Mohamed E Labib
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Innate sensing of chitin and chitosan.

Authors:  Chelsea L Bueter; Charles A Specht; Stuart M Levitz
Journal:  PLoS Pathog       Date:  2013-01-10       Impact factor: 6.823

View more
  4 in total

1.  Flt3-L enhances trans-epithelial migration and antigen presentation of dendritic cells adoptively transferred to genital mucosa.

Authors:  Jaehyung Park; Hannah Frizzell; Hangyu Zhang; Shijie Cao; Sean M Hughes; Florian Hladik; David M Koelle; Kim A Woodrow
Journal:  J Control Release       Date:  2020-10-06       Impact factor: 11.467

Review 2.  Harnessing nanostructured systems for improved treatment and prevention of HIV disease.

Authors:  Maya Monroe; Charles Flexner; Honggang Cui
Journal:  Bioeng Transl Med       Date:  2018-07-27

Review 3.  Recent Advancements in Nanomedicine for 'Cold' Tumor Immunotherapy.

Authors:  Qinjun Chen; Tao Sun; Chen Jiang
Journal:  Nanomicro Lett       Date:  2021-03-16

4.  Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles.

Authors:  Manuel López-López; Angela Fernández-Delgado; María Luisa Moyá; Daniel Blanco-Arévalo; Cecilio Carrera; Rafael R de la Haba; Antonio Ventosa; Eva Bernal; Pilar López-Cornejo
Journal:  Pharmaceutics       Date:  2019-01-30       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.